Peptide blends in research: what a co-lyophilized blend is, when it helps, and when to buy the single compounds
A peptide blend, often called a “stack” in online discussion, is two or more peptides supplied together in a single vial at a fixed mass ratio. The format saves a weighing step and removes dispensing error when peptides are studied in combination, but it fixes the ratio, complicates the certificate, and is the wrong choice for several common experimental designs. This guide explains how blends are made, how to read a blend certificate, how to calculate concentrations, and how to decide between a blend and the individual peptides. For laboratory research use only.
What a co-lyophilized blend is
In a co-lyophilized blend, the component peptides are dissolved together in a defined ratio, dispensed into vials and freeze-dried as one cake (see what lyophilized means). The label states the mass of each component, for example “BPC-157 10 mg + TB-500 10 mg”, and reconstituting the vial gives a solution containing all components at once. This is different from a kit of separate vials, and different from a mixture made in the laboratory from individual stocks. “Stack” is the informal term for the same idea; vendors and laboratories use “blend”.
| Format | Two or more peptides freeze-dried together in one vial at a fixed mass ratio |
| Label states | Mass of each component (not a total) |
| Certificate should state | Identity (MS) and purity (HPLC) for each component separately |
| Concentration after reconstitution | Calculated per component: each mass ÷ diluent volume |
| Main advantage | No weighing or dispensing error when combining peptides; one reconstitution |
| Main limitation | Ratio is fixed; no single-peptide control from the same vial |
| Also called | Peptide stack, combination vial, co-lyophilized peptides |
Why blends exist
Many peptides are studied in the same families of model, and laboratories that want to test whether two or three mechanistically different agents are additive in a tissue or cell model need a reproducible way to combine them. Preparing a combination from separate stocks means two or three weighings, two or three reconstitutions and a mixing step, each of which introduces error, and small vial masses (a few milligrams) make the weighing error proportionally large. A co-lyophilized vial moves the combining step to the manufacturer, where it is done gravimetrically on a larger scale and verified on the certificate. The result is a vial whose component ratio is the same every time it is opened, which is what matters for a repeated experiment.
Reading a blend certificate
A blend certificate has to do more than a single-peptide certificate, and a vendor that does not do it has not characterised the product. Check for:
- One identity result per component. The mass-spectrometry panel should show a peak at each expected mass (≈1,419.5 for BPC-157, ≈4,963 for TB-500, ≈401.9 for GHK-Cu, for example). A single mass, or none, means only one component or none was confirmed.
- One purity result per component. Because the peptides elute at different retention times, the HPLC trace shows a main peak for each; purity should be reported for each peak, not as one number for the whole vial.
- Masses or ratio. The certificate or label should state the mass of each component. Net peptide content, if reported, is per component too; see peptide purity explained.
- Lot number and laboratory. As for any product; see how to read a certificate of analysis.
Calculating concentrations in a blend
Concentration is worked out per component, exactly as for a single peptide, using that component’s mass. A 10 mg + 10 mg blend reconstituted with 2 mL contains 5 mg/mL of each peptide. The molar concentrations differ because the molecular weights differ: 5 mg/mL of BPC-157 (MW 1,419.5) is about 3.5 mM, while 5 mg/mL of TB-500 (MW 4,963) is about 1.0 mM. In a three-peptide blend such as 10 mg + 10 mg + 50 mg, the third component is at five times the mass concentration of the others. The peptide calculator handles one component at a time; run it once per peptide with the same diluent volume. Our guide to sequence, molecular weight and net peptide content covers the mass-to-moles arithmetic.
When a blend is the wrong choice
- You need to vary the ratio. A blend fixes it. Dose–response or ratio-finding work needs the single compounds.
- You need single-peptide control arms. A proper combination experiment compares the combination with each component alone and with vehicle. Those arms cannot come from the blend vial; buy the singles for them (and ideally use the same lots as the blend, which a manufacturer who makes both can often arrange).
- The components need different handling. A peptide that must be used fresh because of methionine oxidation (MOTS-c, for example) should not be co-lyophilized with one that is stable for weeks in solution, because the blend is only as stable as its weakest component. Blends of robust, water-soluble peptides with at most minor oxidation sensitivity, such as BPC-157, thymosin β4 (one methionine) and GHK-Cu, are the sensible cases.
- The components have incompatible solubility or pH needs. A copper complex and a free-thiol peptide, or a peptide that needs acidic diluent and one that needs neutral, do not belong in one vial.
- Analytical work. If the vial will be used as a reference standard or for method development, use single compounds; overlapping peaks complicate every measurement.
Blends supplied by Quantum Peptides
Three co-lyophilized research blends are in the catalogue, each with a lot certificate reporting every component separately: the two-peptide BPC-157 / TB-500 blend, 10 mg + 10 mg; the three-peptide Glow peptide blend (BPC-157 / TB-500 / GHK-Cu), 10 mg / 10 mg / 50 mg; and, in a topical research-serum format rather than a lyophilized vial, GHK-Cu + Snap-8. All three combine peptides that are water-soluble and comparatively stable under the same storage conditions, which is the criterion above. Each single component is also sold on its own, so control arms can be run from the same catalogue. For the two most-asked-about components, see BPC-157 vs TB-500.
Handling
A blend is reconstituted and stored like any lyophilized peptide: diluent down the vial wall, swirl rather than shake, store the powder at −20 °C and solutions at 2–8 °C in the dark, within the working life of the diluent. The reconstitution guide, bacteriostatic vs sterile water and storage guide apply unchanged. Treat the whole vial as having the shelf life of its least stable component.
Frequently asked questions
What is a peptide blend?
Two or more peptides freeze-dried together in one vial at a fixed mass ratio, so that one reconstitution gives a solution containing all of them. “Peptide stack” is the informal term.
Is a blend better than buying the peptides separately?
Neither is better in general. A blend removes weighing and mixing error for a fixed combination; the single compounds are needed whenever the ratio must vary or single-peptide controls are required.
How do I read the purity of a blend?
Per component. The certificate should give an HPLC purity and a mass-spectrometry identity for each peptide in the vial, not one figure for the mixture.
How do I calculate the concentration of each peptide in a blend?
Divide each component’s labelled mass by the diluent volume. 10 mg + 10 mg in 2 mL gives 5 mg/mL of each; the molar concentrations differ with molecular weight.
Can any peptides be blended?
No. Components should share solubility, pH tolerance and stability. A peptide that must be used fresh should not be blended with one that is stable for weeks.
Can I buy peptide blends for human use?
No. Quantum Peptides products are supplied for in-vitro and preclinical laboratory research only, not for human or veterinary use.
Quantum Peptides supplies lyophilised research peptides for in-vitro and preclinical laboratory research only. Products are not for human or veterinary use. This guide describes laboratory formats and handling and is not guidance on administration of any kind.